717 related articles for article (PubMed ID: 29478743)
1. The neutrophil-to-lymphocyte ratio (NLR) predicts short-term and long-term outcomes in gastric cancer patients.
Miyamoto R; Inagawa S; Sano N; Tadano S; Adachi S; Yamamoto M
Eur J Surg Oncol; 2018 May; 44(5):607-612. PubMed ID: 29478743
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in gastric cancer.
Zhang Y; Lu JJ; Du YP; Feng CX; Wang LQ; Chen MB
Medicine (Baltimore); 2018 Mar; 97(12):e0144. PubMed ID: 29561419
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic value of preoperative neutrophil-to-lymphocyte ratio in the elderly patients over 75 years old with gastric cancer].
Zhang X; Li S; Guo Z; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 May; 19(5):526-9. PubMed ID: 27215519
[TBL] [Abstract][Full Text] [Related]
4. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.
Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z
Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313
[TBL] [Abstract][Full Text] [Related]
5. Significance of the preoperative neutrophil-to-lymphocyte ratio in the prognosis of patients with gastric cancer.
Yu L; Lv CY; Yuan AH; Chen W; Wu AW
World J Gastroenterol; 2015 May; 21(20):6280-6. PubMed ID: 26034363
[TBL] [Abstract][Full Text] [Related]
6. Combined analysis of the pre- and postoperative neutrophil-lymphocyte ratio predicts the outcomes of patients with gastric cancer.
Miyatani K; Saito H; Kono Y; Murakami Y; Kuroda H; Matsunaga T; Fukumoto Y; Osaki T; Ashida K; Fujiwara Y
Surg Today; 2018 Mar; 48(3):300-307. PubMed ID: 28916967
[TBL] [Abstract][Full Text] [Related]
7. Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio Cannot Predict Lymph Node Metastasis and Prognosis in Patients with Early Gastric Cancer: a Single Institution Investigation in China.
Zhu GS; Tian SB; Wang H; Ma MG; Liu Y; Du HS; Long YP
Curr Med Sci; 2018 Feb; 38(1):78-84. PubMed ID: 30074155
[TBL] [Abstract][Full Text] [Related]
8. A novel predictive model based on preoperative blood neutrophil-to-lymphocyte ratio for survival prognosis in patients with gastric neuroendocrine neoplasms.
Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM
Oncotarget; 2016 Jul; 7(27):42045-42058. PubMed ID: 27275541
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of preoperative neutrophils to lymphocytes ratio in patients resected for gastric cancer.
Graziosi L; Marino E; De Angelis V; Rebonato A; Cavazzoni E; Donini A
Am J Surg; 2015 Feb; 209(2):333-7. PubMed ID: 25190544
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Resectable Gastroesophageal Junction and Gastric Adenocarcinoma.
Wang SC; Chou JF; Strong VE; Brennan MF; Capanu M; Coit DG
Ann Surg; 2016 Feb; 263(2):292-7. PubMed ID: 25915915
[TBL] [Abstract][Full Text] [Related]
11. Impact of Preoperative Neutrophil to Lymphocyte Ratio and Postoperative Infectious Complications on Survival After Curative Gastrectomy for Gastric Cancer: A Single Institutional Cohort Study.
Mohri Y; Tanaka K; Toiyama Y; Ohi M; Yasuda H; Inoue Y; Kusunoki M
Medicine (Baltimore); 2016 Mar; 95(11):e3125. PubMed ID: 26986164
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil-Lymphocyte Ratio as a Prognostic Marker for Lung Adenocarcinoma After Complete Resection.
Takahashi Y; Kawamura M; Hato T; Harada M; Matsutani N; Horio H
World J Surg; 2016 Feb; 40(2):365-72. PubMed ID: 26493696
[TBL] [Abstract][Full Text] [Related]
13. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
Shao N; Cai Q
Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
[TBL] [Abstract][Full Text] [Related]
14. Preoperative Neutrophil to Lymphocyte Ratio and Lymphocyte to Monocyte Ratio are Prognostic Factors in Gastric Cancers Undergoing Surgery.
Lieto E; Galizia G; Auricchio A; Cardella F; Mabilia A; Basile N; Del Sorbo G; Castellano P; Romano C; Orditura M; Napolitano V
J Gastrointest Surg; 2017 Nov; 21(11):1764-1774. PubMed ID: 28752404
[TBL] [Abstract][Full Text] [Related]
15. An increase in the neutrophil-to-lymphocyte ratio during adjuvant chemotherapy indicates a poor prognosis in patients with stage II or III gastric cancer.
Mori M; Shuto K; Kosugi C; Narushima K; Hayashi H; Matsubara H; Koda K
BMC Cancer; 2018 Dec; 18(1):1261. PubMed ID: 30558575
[TBL] [Abstract][Full Text] [Related]
16. The preoperative neutrophil-lymphocyte ratio predicts recurrence and survival among patients undergoing R0 resections of adenocarcinomas of the esophagogastric junction.
Yuan D; Zhu K; Li K; Yan R; Jia Y; Dang C
J Surg Oncol; 2014 Sep; 110(3):333-40. PubMed ID: 24889121
[TBL] [Abstract][Full Text] [Related]
17. Exploring the value of new preoperative inflammation prognostic score: white blood cell to hemoglobin for gastric adenocarcinoma patients.
Zheng HL; Lu J; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Li P; Zheng CH; Huang CM
BMC Cancer; 2019 Nov; 19(1):1127. PubMed ID: 31752770
[TBL] [Abstract][Full Text] [Related]
18. Prealbumin and lymphocyte-based prognostic score, a new tool for predicting long-term survival after curative resection of stage II/III gastric cancer.
Shen Q; Liu W; Quan H; Pan S; Li S; Zhou T; Ouyang Y; Xiao H
Br J Nutr; 2018 Dec; 120(12):1359-1369. PubMed ID: 30370885
[TBL] [Abstract][Full Text] [Related]
19. Predictive Value of the Neutrophil/Lymphocyte Ratio in Peritoneal and/or Metastatic Disease at Staging Laparoscopy for Gastric and Esophageal Adenocarcinoma.
Grenader T; Plotkin Y; Mohammadi B; Dawas K; Hashemi M; Mughal M; Bridgewater JA
J Gastrointest Cancer; 2015 Sep; 46(3):267-71. PubMed ID: 25952408
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy.
Lee S; Oh SY; Kim SH; Lee JH; Kim MC; Kim KH; Kim HJ
BMC Cancer; 2013 Jul; 13():350. PubMed ID: 23876227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
